tradingkey.logo

Inspire Veterinary Partners Inc

IVP
0.034USD
0.0000.00%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
225.42KMarktkapitalisierung
VerlustKGV TTM

Inspire Veterinary Partners Inc

0.034
0.0000.00%

mehr Informationen über Inspire Veterinary Partners Inc Unternehmen

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals throughout the United States. The Company specializes in small animal general practice hospitals which serve all types of companion pets, emphasizing canine and feline breeds and including equine care. Services provided at its hospitals include preventive care for companion animals, consisting of annual health exams, including parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; skin and coat health and many breed specific preventive care services. Surgical offerings include all soft tissue procedures, such as spays and neuters, mass removals, splenectomies and can also include gastropexies, orthopedic procedures and other types of surgical offerings based on a doctor’s training. In many locations, additional means of care and alternative procedures are also offered, such as acupuncture, chiropractic and other health and wellness offerings.

Inspire Veterinary Partners Inc Informationen

BörsenkürzelIVP
Name des UnternehmensInspire Veterinary Partners Inc
IPO-datumAug 30, 2023
CEOCarr (Kimball)
Anzahl der mitarbeiter113
WertpapierartOrdinary Share
GeschäftsjahresendeAug 30
Addresse780 Lynnhaven Pkwy #400
StadtVIRGINIA BEACH
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl23452
Telefon17572883088
Websitehttps://www.inspirevet.com/
BörsenkürzelIVP
IPO-datumAug 30, 2023
CEOCarr (Kimball)

Führungskräfte von Inspire Veterinary Partners Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kimball Carr
Mr. Kimball Carr
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
11.00
--
Mr. Charles Stith Keiser
Mr. Charles Stith Keiser
Director
Director
10.00
--
Dr. Erinn Thomas-Mackey
Dr. Erinn Thomas-Mackey
Director
Director
2.00
--
Mr. Richard Paul Frank
Mr. Richard Paul Frank
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Anne Murphy
Ms. Anne Murphy
Independent Director
Independent Director
--
--
Mr. Timothy Watters
Mr. Timothy Watters
Independent Director
Independent Director
--
--
Mr. Larry Alexander
Mr. Larry Alexander
Independent Director
Independent Director
--
--
Mr. Phillip Balatsos
Mr. Phillip Balatsos
Independent Director
Independent Director
--
--
Ms. Alexandra Quatri
Ms. Alexandra Quatri
Vice President of Medical Operations
Vice President of Medical Operations
--
--
Ms. Laura Johnson
Ms. Laura Johnson
Vice President of Operations
Vice President of Operations
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kimball Carr
Mr. Kimball Carr
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
11.00
--
Mr. Charles Stith Keiser
Mr. Charles Stith Keiser
Director
Director
10.00
--
Dr. Erinn Thomas-Mackey
Dr. Erinn Thomas-Mackey
Director
Director
2.00
--
Mr. Richard Paul Frank
Mr. Richard Paul Frank
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Anne Murphy
Ms. Anne Murphy
Independent Director
Independent Director
--
--
Mr. Timothy Watters
Mr. Timothy Watters
Independent Director
Independent Director
--
--

Umsatzaufteilung

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: 3 hours ago
Aktualisiert: 3 hours ago
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
UBS Financial Services, Inc.
0.10%
DRW Securities, LLC
0.03%
Andere
99.87%
Aktionäre
Aktionäre
Anteil
UBS Financial Services, Inc.
0.10%
DRW Securities, LLC
0.03%
Andere
99.87%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
0.13%
Andere
99.87%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
29
425.59K
0.13%
+331.09K
2025Q3
30
85.70K
2.35%
-162.35K
2025Q2
36
227.92K
10.75%
+186.48K
2025Q1
37
233.23K
11.15%
+199.50K
2024Q4
35
26.63K
1.96%
+14.11K
2024Q3
29
12.19K
10.24%
+9.83K
2024Q2
26
1.53K
5.46%
+829.00
2024Q1
24
680.00
3.62%
+167.00
2023Q4
22
514.00
27.03%
+264.00
2023Q3
15
280.00
16.84%
+280.00

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
UBS Financial Services, Inc.
12.15K
0.34%
+200.00
+1.67%
Jun 30, 2025
DRW Securities, LLC
95.11K
0.25%
+95.11K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
10.62K
0.29%
+580.00
+5.78%
Jun 30, 2025
Citi Investment Research (US)
5.29K
0.01%
+5.29K
--
Sep 30, 2025
Tower Research Capital LLC
2.72K
0.08%
+554.00
+25.58%
Jun 30, 2025
Wells Fargo Advisors
15.00
0%
+11.00
+275.00%
Jun 30, 2025
Lawrence (Alexander)
1.00
0%
--
--
Aug 08, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
Datum
Ex-Dividendentag
Art
Verhältnis
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Jan 23, 2025
Merger
25→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
Apr 17, 2024
Merger
100→1
KeyAI